Literature DB >> 6272281

Antibodies specific for the polyoma virus middle-size tumor antigen.

G Walter, M A Hutchinson, T Hunter, W Eckhart.   

Abstract

We have obtained antibodies specific for the polyoma virus middle-size tumor antigen (middle T antigen) by immunizing rabbits with a synthetic peptide, Lys-Arg-Ser-Arg-His-Phe, corresponding to the six carboxy-terminal amino acids of the middle T antigen predicted from the nucleotide sequence of polyoma DNA. The antipeptide serum precipitates the polyoma middle T antigen but not the small or large tumor antigens, and precipitation is inhibited in the presence of the peptide. Two cellular proteins, 30,000 and 26,000 daltons, are also precipitated specifically by the antipeptide serum and may have amino acid sequences related to the peptide. Two other cellular proteins, 33,000 and 25,000 daltons, are precipitated only in the presence of the peptide and may associate with it in cell extracts. Antisera directed against synthetic peptides are likely to be important in various ways, including the production of antibodies directed against particular determinants and the recognition of unknown proteins whose genes have been analyzed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272281      PMCID: PMC320283          DOI: 10.1073/pnas.78.8.4882

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Construction and analysis of viable deletion mutants of polyoma virus.

Authors:  G Magnusson; P Berg
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

3.  Comparisons of two early gene functions essential for transformation in polyoma virus and SV-40.

Authors:  M M Fluck; T L Benjamin
Journal:  Virology       Date:  1979-07-15       Impact factor: 3.616

4.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

5.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

6.  Host range selection of transformation-defective hr-t mutants of polyoma virus.

Authors:  R J Staneloni; M M Fluck; T L Benjamin
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

7.  Host range mutants of polyoma virus.

Authors:  T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

8.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

9.  An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates.

Authors:  W Eckhart; M A Hutchinson; T Hunter
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

10.  Phosphorylation of polyoma T antigens.

Authors:  B S Schaffhausen; T L Benjamin
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

View more
  26 in total

1.  Purified polyoma virus medium T antigen has tyrosine-specific protein kinase activity but no significant phosphatidylinositol kinase activity.

Authors:  W Koch; A Carbone; G Walter
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

2.  Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.

Authors:  T Tanaka; D J Slamon; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 3.  Membrane antigens associated with infection, transformation, and tumorigenesis by polyoma virus.

Authors:  I P Witz; G Meyer
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  On the nature of crossreactions observed with antibodies directed to defined epitopes.

Authors:  E A Nigg; G Walter; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

5.  Monoclonal antibodies against polyoma virus tumor antigens.

Authors:  S M Dilworth; B E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  Identification of the tyrosine protein kinase from LSTRA cells by use of site-specific antibodies.

Authors:  J E Casnellie; L E Gentry; L R Rohrschneider; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Differential subcellular localization of in vivo-phosphorylated and nonphosphorylated middle-sized tumor antigen of polyoma virus and its relationship to middle-sized tumor antigen phosphorylating activity in vitro.

Authors:  K Segawa; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Antiserum specific for the carboxy terminus of the transforming protein of Rous sarcoma virus.

Authors:  B M Sefton; G Walter
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

9.  Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide.

Authors:  E A Nigg; B M Sefton; T Hunter; G Walter; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Complexes of polyoma virus medium T antigen and cellular proteins.

Authors:  T Grussenmeyer; K H Scheidtmann; M A Hutchinson; W Eckhart; G Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.